Source: Press Release Jet

Press Release: Klogene Therapeutics : Klogene and Kogenix announce merger

Klogene Therapeutics, Inc. and Kogenix Therapeutics, Inc. today announced the merger of the two companies. The combined company, using the name Klogene, is focused on Klotho, a naturally occurring pleiotropic human protein that has been shown to have potential therapeutic effects in neurodegenerative diseases such as Alzheimer's as well as kidney disease, certain cancers, and more. Higher...Read the full story at https://pressreleasejet.com/news/klogene-and-kogenix-announce-merger.html

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Carmela Abraham's photo - Co-Founder of Klogene Therapeutics

Co-Founder

Carmela Abraham

CEO Approval Rating

75/100

Read more